[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-359266-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-359266-en":135},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","segment-specific-ptv-margins-for-rectal-cancer-radiotherapy-on-the-mr-linac-characterization-of-rectal-motion-and-dosimetric-validation","Segment-specific PTV margins for rectal cancer radiotherapy on the MR-Linac - characterization of rectal motion and dosimetric validation","","Dose escalation in rectal radiotherapy offers potential benefits for complete response and organ preservation, but the optimal expansion margins for rectal lesions remain insufficiently defined. This study uses high-resolution real-time MR-guided radiotherapy imaging to quantify rectal motion uncertainties, determine segment-based planning target volume (PTV) margins, and validate dosimetric performance. The findings support more precise dose escalation while improving target coverage and reducing organ-at-risk exposure.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/segment-specific-ptv-margins-for-rectal-cancer-radiotherapy-on-the-mr-linac-characterization-of-rectal-motion-and-dosimetric-validation/359266/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/segment-specific-ptv-margins-for-rectal-cancer-radiotherapy-on-the-mr-linac-characterization-of-rectal-motion-and-dosimetric-validation/359266.png","ImageObject",300,407,{"name":42,"@type":43},"Jake","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in rectal radiotherapy?","Question",{"text":63,"@type":64},"Optimal expansion margins for rectal lesions are unclear for dose escalation, largely because rectal motion creates both interfractional and intrafractional uncertainties. The study targets how to characterize these uncertainties and translate them into appropriate PTV margins.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were rectal motion and margins evaluated in the study?",{"text":68,"@type":64},"MR images were collected pre-treatment, during each fraction, and post-treatment for 22 advanced rectal cancer patients on a 1.5T MR-Linac. Margins were derived by isotropically expanding the segmented CTV, with adequacy defined by covering 95% of CTV in 90% of fractions.",{"name":70,"@type":61,"acceptedAnswer":71},"What dosimetric comparison was used for validation?",{"text":72,"@type":64},"Dosimetric validation was performed on 15 patients by comparing segmented margin expansion against literature-based uniform margins. The goal was to assess target coverage and reduce dose to organs at risk (OARs).",{"name":74,"@type":61,"acceptedAnswer":75},"What were the main conclusions about segment-specific margins?",{"text":76,"@type":64},"Rectal motion variability depended on segment location, with the upper rectum requiring larger margins than the middle and lower segments. The segmented expansion strategy provided adequate target coverage while substantially sparing OARs, with reported dose reductions ranging from 7.4% to 44.5%.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},359266,1790192928,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,131],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":128,"slug":130},10,"Lifestyle","lifestyle",{"id":132,"doc_module":4,"doc_module_name":25,"category_name":133,"show_sort_weight":101,"slug":134},19,"General","general",{"code":4,"msg":86,"data":136},{"doc_id":83,"user_id":137,"nickname":42,"user_avatar":138,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":128,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":33,"preview_urls":150},962084928904,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Yang et al. Radiation Oncology (2026) 21:43 [https://doi.org/10.1186/s13014-026-02806-z](https://doi.org/10.1186/s13014-026-02806-z)  \nRadiation Oncology  \nRESEARCH Open Access  \nSegment-specific PTV margins for rectal cancer radiotherapy on the MR-Linac: characterization of rectal motion and dosimetric validation  \nWang Yang 1,2,3†, Lei Yu 1,2,3†, Yiwen Hu 1,2,3†, Hui Zhang 1,2,3, Menglong Zhou 1,2,3, Yajie Chen 1,2,3, Yaqi Wang 1,2,3, Jian Qiao 1,2,3, Yanju Yang 1,2,3, Jun Zhao 1,2,3, Weigang Hu 1,2,3, Zhen Zhang 1,2,3* and Fan Xia 1,2,3*  \nAbstract  \nBackground Dose escalation in rectal radiotherapy shows promise for improving complete response rates and organ preservation, yet optimal expansion margins for rectal lesions remain unclear. This study aims to utilize highresolution real-time imaging from MR-guided radiotherapy to characterize rectal motion uncertainties, optimize planning target volume (PTV) margins, and validate dosimetric outcomes, thereby enhancing the precision in rectal cancer dose escalation.  \nMethods A cohort of 22 advanced rectal cancer patients undergoing neoadjuvant radiotherapy on a 1. 5T MR-Linac. Pre-treatment, intra-fraction, and post-treatment MR images were acquired for each fraction, with the rectum delineated according to the distance from the anus (upper, middle, lower) . Inter-and intrafractional margins were determined by isotropic expansion of the segmented clinical target volume (CTV), with adequacy defined as covering 95% of the CTV volume in 90% of all fractions. Dosimetric validation was performed on 15 patients (10 internal, 5 external), comparing the segmental margins with literature-based uniform margins to assess target coverage and organs at risk (OARs) sparing.  \nResults Rectal motion variability was segment-dependent, with the upper rectum requiring the largest marginsand the lower rectum the smallest. Interfractional margins for the upper, middle, and lower rectum were 13 mm,  \n7 mm, and 6.5 mm, respectively. Intrafractional analysis revealed that treatment duration also influenced margin requirements, with 7 mm for the upper rectum and 3 mm for the middle and lower rectum sufficient for durations under 30 min; longer durations necessitated slightly larger margins. Dosimetric analysis confirmed that the segmented margin expansion strategy achieves adequate target coverage while substantially sparing OARs with dose reductions ranging from 7.4% to 44. 5% .  \n†Wang Yang, Lei Yu andYiwen Hu contributed equally to this work.  \n*Correspondence:  \nZhen Zhang [zhen_zhang@fudan.edu.cn](zhen_zhang@fudan.edu.cn)[ ](zhen_zhang@fudan.edu.cn)Fan Xia [fanxia@fudan.edu.cn](fanxia@fudan.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nYang et al. Radiation Oncology (2026) 21:43 Page 2 of 10  \nConclusions Segment-specific margin expansion suggest a potential improvement for rectal radiotherapy, ens","cbCair1r4tR4T2w9","https://ap.wps.com/l/cbCair1r4tR4T2w9","pdf",1556792,"English","# Abstract\n# Methods\n# Results\n# Conclusions\n# Keywords\n# Introduction","[{\"question\":\"What problem does the study address in rectal radiotherapy?\",\"answer\":\"Optimal expansion margins for rectal lesions are unclear for dose escalation, largely because rectal motion creates both interfractional and intrafractional uncertainties. The study targets how to characterize these uncertainties and translate them into appropriate PTV margins.\"},{\"question\":\"How were rectal motion and margins evaluated in the study?\",\"answer\":\"MR images were collected pre-treatment, during each fraction, and post-treatment for 22 advanced rectal cancer patients on a 1.5T MR-Linac. Margins were derived by isotropically expanding the segmented CTV, with adequacy defined by covering 95% of CTV in 90% of fractions.\"},{\"question\":\"What dosimetric comparison was used for validation?\",\"answer\":\"Dosimetric validation was performed on 15 patients by comparing segmented margin expansion against literature-based uniform margins. The goal was to assess target coverage and reduce dose to organs at risk (OARs).\"},{\"question\":\"What were the main conclusions about segment-specific margins?\",\"answer\":\"Rectal motion variability depended on segment location, with the upper rectum requiring larger margins than the middle and lower segments. The segmented expansion strategy provided adequate target coverage while substantially sparing OARs, with reported dose reductions ranging from 7.4% to 44.5%.\"}]","Segment-specific PTV margins for rectal cancer radiotherapy on the MR-Linac - characterization of rectal motion and dosimetric validation | PDF",1790136543,25,[151,155,159,163],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4cf7755e8182038589292b361c46ef52.webp",983,1310,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d5babf5a3278d84b68d05ed9c62fbf16.webp",982,1309,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/62d3f6e7e94fabf754f5786253f91575.webp",981,1308,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fdd15d6544f7f084665012a402ea3d1a.webp",980,1306]